. Introduction
Multifunctional nanomaterials able to integrate both diagnosis and therapy into a single multimodal nanoplatform have emerged as a promising tool for target-specifi c delivery of imaging and therapeutic agents in biomedical applications in the era of molecular medicine and personalized medicine. [ 1 ] Each imaging modality has its own advantages and intrinsic limitations in terms of sensitivity, spatial resolution, and complexity. [ 1b , 2 ] Thus, it should be possible to rationally design a platform that combines imaging modalities with high sensitivity, for example, positron emission tomography (PET) and optical imaging, with other modalities having high spatial resolution, for example, computed tomography (CT) or MRI, to acquire complementary information, leading to more accurate diagnoses. [ 1b , 2 , 3 ] Combining two therapeutic modalities is also helpful in overcoming serious limitations encountered by each therapy when used alone. [ 1b,d , 4 ] For instance, chemotherapy, an important modality in cancer treatment, is limited by drug resistance and toxic side effects, making targeted drug delivery and controlled drug release major challenges. However, based on the attractive photothermal effect of some plasmonic nanomaterials, the combination of photothermal agents and chemotherapy is an encouraging approach to achieve enhanced cancer killing effi ciency through synergistic effects. [ 4d , 5 ] Further, under these conditions, smaller drug doses may be suffi cient for the desired therapeutic outcome, since cells exposed to higher temperature are more susceptible to certain chemotherapy drugs.
To improve specifi city, recognition elements, such as folic acids, [ 6 ] peptides, [ 7 ] and, of particular interest, aptamers, [ 8 ] are commonly incorporated for targeted delivery. Aptamers are single-stranded oligonucleotides generated from an in vitro selection process called SELEX (systematic evolution of ligands by exponential enrichment). They can bind to their targets, including small molecules, proteins, and even intact cells and tissues, with excellent specifi city and high affi nity. [ 9 ] Signifi cant advantages, such as ease of synthesis and surface modifi cation, long-term stability, lack of immunogenicity, and rapid tissue penetration, make aptamers ideal candidates for molecular recognition, [ 10 ] drug delivery, [ 11 ] cancer diagnosis, and therapy. [ 12 ] Several aptamer conjugates functionalized with various nanomaterials have already been reported. These nanocarriers integrate such capabilities as fl uorescence imaging, MRI, and the photothermal effect into one single platform. [ 13 ] Building on the original sgc8 aptamer. [ 17 ] Two PEG units are incorporated between the sgc8 aptamer and the (AGC) 7 extended sequence in order to reduce the steric effects of binding to target cells and to locate the fl uorophore away from the gold surface to allow further fl ow cytometry study (Figure 2 ) . The intercalation of Dox into the nanorose, which also serves as a photothermal agent, results in a single multifunctional nanostructure integrating simultaneous photothermal cell killing and drug release (photothermal/chemotherapy) for enhanced antitumor killing efficiency and reduced toxic side effects. In addition, dual modality this design, the present paper describes a novel nanoplatform performing fi ve distinct functions synergistically and effectively. To accomplish this, we have prepared gold-coated iron oxide (Fe 3 O 4 @Au) nanoroses with several excellent features, including biocompatibility, NIR absorption, and superparamagnetic properties. [ 14 ] Based on these properties, the nanoroses can be used as both photothermal agents for photothermal therapy and contrast agents for MRI. They can also be easily conjugated with aptamers via thiolate bonding, for example, sgc8 aptamers, which specifi cally recognize CCRF-CEM leukemia cells, as a model for targeted imaging and therapy. Additionally, the chemotherapeutic agent doxorubicin (Dox) can be intercalated into the GC base pairs in the extended part of the aptamers as a drug delivery platform. [ 8b , 12c , 15 ] By combining these capabilities, we have developed a drug-loaded Fe 3 O 4 @Au nanorose platform with fi ve distinct functions for simultaneous imaging and therapy: targeting with aptamers, dual molecular imaging (MRI/optical imaging) and dual therapy (photothermal /chemotherapy) ( Figure 1 ).
. Results and Discussion

. Synthesis and Characterization
As shown in Figure 2 , this fi ve-function nanorose contains four components: 1) the Fe 3 O 4 @Au nanorose, which acts as both a photothermal agent and an MRI contrast agent; 2) surface modifi cation with a carboxylic acid-PEG derivative (SH-PEG-COOH) and a capture probe, 5′-(GCT) 7 -T 10 -SH-3′, for Dox loading and hybridization with sgc8 aptamer; 3) sgc8 aptamer, modifi ed with a desired fl uorophore at the 3′-end and a 21-base (AGC) 7 extension at the 5′-end, to target CCRF-CEM cells and act as a carrier for Dox and 4) Dox, acting as both a chemotherapeutic agent and an optical imaging agent, which is loaded through both intercalation into the extended GC base pairs and electrostatic interaction with the carboxyl groups on the nanorose surface. [ 12c , 16 ] Dox loading capacity is signifi cantly enhanced by fusing the (AGC) 7 repeating oligonucleotide to 2) A carboxylic acid-PEG derivative (SH-PEG-COOH) and a capture probe, 5′-(GCT) 7 -T 10 -SH-3′, were modifi ed on the surface of nanoroses via gold-thiol bonds. 3) Sgc8 aptamer with a 21-base (AGC) 7 extension was hybridized with the capture probe to target CCRF-CEM cells and act as a carrier for Dox. 4) Dox is loaded on nanoroses through both intercalation into the extended GC base pairs and electrostatic interaction with the carboxyl groups on the nanorose surface.
13:1 based on the EDS spectrum, which was higher than that obtained from inductively coupled plasma-atomic emission spectroscopy (ICP-AES) (4.5:1), as a consequence of the existence of uncoated Fe 3 O 4 nanoparticles. The UV-Vis-NIR absorption spectrum in Figure 3 f showed that the nanorose solution has an obvious absorption in the NIR window at 805 nm, which is in the wavelength range for maximum depth of penetration in tissue. The aqueous nanorose solution was dark blue (inset in Figure 3 f), and its temperature can be increased to around 50 °C with an 810 nm continuous wave laser irradiation at 1.3 W cm −2 for 10 min ( Figure S1 , Supporting Information), indicating that nanoroses can effi ciently convert light to heat for photothermal therapy. The potential of nanoroses as T 2 -based contrast agents for MRI was demonstrated with 1) transverse relaxivity r 2 of 80 m M −1 s −1 ( Figure S2a , Supporting Information) and 2) dramatically decreased signal intensity of the T 2 -weighted MRI with increasing Fe concentration ( Figure S2b , Supporting Information).
. Surface Modifi cation of Nanoroses for Drug Delivery and Cancer Cell Targeting
As shown in Figure 2 , the surfaces of nanoroses were modifi ed with SH-PEG-COOH via gold-thiol bonds, which can stabilize imaging, that is, optical imaging and MRI, can provide complementary information for early and accurate cancer diagnosis, as well as real-time therapeutic drug monitoring.
Nanoroses were prepared following the slightly modifi ed protocol reported previously. [ 14, 18 ] The Fe 3 O 4 nanoparticle cores were synthesized in the presence of dextran. Then, nanoroses were formed by the reduction of HAuCl 4 onto the surfaces of Fe 3 O 4 with hydroxylamine as a seeding agent and dextrose as a mild reducing agent. Transmission electron microscopy (TEM) images showed that the Fe 3 O 4 core was small in size (estimated to be 3-5 nm in diameter) ( Figure 3 a) and that the nanorose with fl ower-like cluster shape was around 70 nm in diameter (Figure 3 b) . The hydrodynamic diameter distribution determined by dynamic light scattering (DLS) in Figure 3 c showed that the average nanorose diameter was 78.4 ± 6.4 nm, which was consistent with the TEM result. It has been reported that the gold shell thickness is ≈1-3 nm. [ 14, 18 ] The nanorose stayed homogenous for at least 6 days at 4 °C and can be well dispersed after sonication. The molar concentration of the nanoroses was calculated as reported previously. [ 18 ] A representative energy-dispersive X-ray spectroscopy [ 19 ] line scan across the nanorose during scanning transmission electron microscope (STEM) imaging confi rmed that Fe and O were present throughout the cluster diameter and that Au was on the outer surface (Figure 3 d,e) . The Au/Fe mass ratio was about loading on each nanorose. The stability of the nanorose-sgc8 in physiological environments, such as serum-containing cell culture media was tested, indicating that it can be stable against degradation and digestion of nuclease as a result of the high oligonucleotide loading. [ 20 ] To demonstrate that the conjugated aptamer maintains its binding affi nity and specifi city, the binding of nanorose-sgc8 toward target and control cancer cells was studied by fl ow cytometry. It has been reported that sgc8 can specifi cally bind to cell membrane receptor protein tyrosine kinase (PTK 7) with high affi nity ( K d in the n M range). [ 9c , 21 ] CCRF-CEM cells (acute lymphoblastic leukemia T-cells), with highly expressed PTK 7 on their cell membranes, were chosen as target cancer cells, while Ramos cells (acute lymphoblastic leukemia B-cells), with no expression of PTK7 on the cell membrane, were used as negative control cells. In Figure 4 a, a stronger fl uorescence signal was observed for CCRF-CEM cells treated with nanorosesgc8 (with 165 n M sgc8) than with free sgc8 (200 n M ), indicating that a multivalent-mediated enhancement in affi nity arises when multiple aptamers on the surface of a nanoparticle carrier simultaneously bind to the receptors on the cell membrane. This signifi cant fl uorescence enhancement was also monitored the particles and enable the loading of anticancer drug Dox via electrostatic interactions. A capture probe with SH modifi cation at the 3′-end was simultaneously conjugated on the nanoroses to hybridize with sgc8 for targeting and also to load Dox through intercalation into GC base pairs in the extended part of the aptamers (Table S1 , Supporting Information). The results showed that each nanorose possessed about 125 ± 4 sgc8, providing the possibility of multivalent effect when binding to target cells. Dox loading onto the nanorose-sgc8 hybrid (nanorose-sgc8-Dox) was confi rmed by monitoring the fl uorescence quenching of Dox. Based on the titration data ( Figure S3 , Supporting Information), we estimated that 48 ± 2% of Dox was bound to the carboxyl group by electrostatic interactions and that 52 ± 3% was intercalated into the GC base pairs. However, it's also possible that Dox can be adsorbed directly onto the gold surface due to hydrophobic interaction, that is, the interaction between the aromatic rings with the gold surface. As calculated, the loading effi ciency of Dox (the amount of Dox loaded divided by the amount of nanorose-sgc8 used) was estimated to be about 498 μ g Dox mg −1 (49.8 wt%) for nanorose-sgc8. DLS and zeta potential tests ( Figure S4 , Supporting Information), also confi rmed successful aptamer conjugation and effi cient Dox we propose that Dox bound to aptamers enters the lysosome of CCRF-CEM cells, where it is rapidly released at low pH. A further rapid release of Dox may be observed after exposure to laser irradiation, which increases the temperature by the photothermal effect. [ 24 ] 
. Nanorose Complex for Chemotherapy and Photothermal Therapy
To assess the specifi city of our targeted drug delivery system, we investigated the in vitro cytotoxicity of nanorose-sgc8-only, Dox-only, and nanorose-sgc8-Dox for two leukemia cell lines. Both CCRF-CEM and Ramos cells showed high cell viability (above 93%) after incubation with a series of concentrations of nanorose-sgc8-only, indicating that our probe has excellent biocompatibility ( Figure S8 , Supporting Information). Dox-only and nanorose-sgc8-Dox exhibited dose-dependent cytotoxicity behavior to CCRF-CEM cells, as well as Ramos cells. shows that the inhibition concentration (IC 50 ) of nanorose-sgc8-Dox to CCRF-CEM cells was 1.1 μ M , which is quite similar to that for Dox-only (IC 50 = 1.2 μ M ), demonstrating that nanorosesgc8-only did not affect the killing effi ciency of Dox to CCRF-CEM cells. For Ramos cells, the cell viability of 47.1 ± 3.8% with Dox-only treatment (3.0 μ M ) increased to 87.6 ± 2.5% with nanorose-sgc8-Dox treatment. This can be attributed to the lack of PTK7 expression on the surface of Ramos cells, indicating using confocal fl uorescence microscopy ( Figure S5a To confi rm that nanorose-sgc8 can be internalized into target cells for further therapy application, an internalization study was carried out at 37 °C with trypsin treatment. It is known that trypsin treatment can be used to remove the surface binding of sgc8 with target cells. [ 22 ] For CCRF-CEM cells, sgc8 was internalized prior to the addition of trypsin at 37 °C, but the surfacebound sgc8 was removed by trypsinization at 4 °C. The fl uorescence signal was stronger at 37 °C than that at 4 °C after trypsin treatment, showing that nanorose-sgc8 was internalized at 37 °C. The bar graph in Figure 4 f indicated that Ramos cells have neglectable binding with nanorose-sgc8 no matter at 4 °C or 37 °C. It has been reported that free sgc8 can be internalized and delivered into the lysosomes as a result of PTK7-mediated endocytosis. [ 22 ] To further evaluate whether nanorose-sgc8 could enter the lysosomes in a manner similar to free sgc8, a red dye, tetramethylrhodamine (TAMRA), and a green dye, LysoSensor, a pH-dependent lysosome marker, were used to label the aptamer and lysosomes of CCRF-CEM cells, respectively, for a colocalization study. The green fl uorescence for LysoSensor and the red fl uorescence for sgc8 or nanorose-sgc8 overlapped well and produced the merged yellow fl uorescence inside the CCRF-CEM cells, indicating that both sgc8 and nanorose-sgc8 were internalized by the cell through the endocytosis process ( Figure S6 , Supporting Information). Consistent with the fl ow cytometry results, stronger red fl uorescence was observed for cells incubated with nanorose-sgc8 ( Figure S6a ) compared to a higher concentration of free sgc8 ( Figure S6b , Supporting Information), indicating an improved uptake effi ciency of nanorose-sgc8 by CCRF-CEM cells.
To evaluate Dox release kinetics, we incubated nanorose-sgc8-Dox in phosphate buffered saline (PBS) buffer at different pH values (pH 5.0 and 7.4) and different temperatures (25 °C, 37 °C, 65 °C) . The release of Dox was pH-and temperaturedependent, with faster release in acidic environments and at higher temperatures ( Figure S7 , Supporting Information). It has been reported that physically bound Dox is released faster at mildly acidic pH values than at neutral pH, as a consequence of weakened binding between Dox and the partially neutralized carboxyl groups. [ 23 ] In addition, Dox intercalated into GC base pairs in the extended aptamers is released faster via degradation of nucleotides by serum nucleases and dehybridization of aptamer at high temperature. [ 8b , 12c ] Based on these fi ndings, 
. Nanorose Complex for Optical Imaging and MRI
The specifi c binding and release of Dox from nanorose-sgc8-Dox was further studied by co-localization with the LysoSensor using confocal fl uorescence microscopy. From Figure 6 a, it can be seen that the green fl uorescence from the LysoSensor and the red fl uorescence from the released Dox overlapped well, producing a yellow signal inside the CCRF-CEM cells. This result demonstrated that nanorose-sgc8-Dox can enter the cells through endocytosis process and reside in their lysosomes. Therefore, the dissolution of nanorose-sgc8-Dox in acidic cellular lysosomes became a trigger factor for Dox release in our system. A very weak red signal was observed in Ramos cells (Figure 6 b) , which resulted from negligible nonspecifi c binding. These results additionally support our nanorose-sgc8-Dox as a highly promising platform for selective and comprehensive cancer cell diagnosis and therapy.
Since most biological samples exhibit virtually no magnetic background, high sensitivity can be achieved using magnetic nanoparticles for MRI detection of biological samples, even without purifi cation. Hence, an effective magnetic relaxation switch (MRSw) was developed based on cluster formation or dissociation when MNPs bind to specifi c targets, which leads to a change in the transverse or spin-spin relaxation time ( T 2 ). [ 26 ] We investigated the potential of using nanorose-sgc8 for specifi c detection of target cancer cells by T 2 measurement and MRI. When the nanorose-sgc8 hybrids bind to CCRF-CEM cells through the specifi c interaction between receptors on the cell membrane and aptamers on the nanorose surface, clusters formed on the cell membrane, resulting in coupling of the magnetic spin moment and decreased T 2 . Figure 7 a shows a larger Δ T 2 caused by nanorose-sgc8 with CCRF-CEM cells, compared to nanorose-sgc8 with Ramos cells, resulting from the overexpressed PTK7 receptors on CCRF-CEM cells. Next, T 2 -weighted MRI images were further taken after CCRF-CEM and Ramos cells were treated with different concentrations of nanorose-sgc8. that nonspecifi c uptake of Dox was minimized by the formation of a stable nanorose-sgc8-Dox conjugate. The cytotoxicity results demonstrated that the drug delivery system has excellent selectivity compared to conventional chemotherapy using Dox-only, an important benefi t for reducing the side effects of chemotherapy.
To prove that nanorose-sgc8 can also be used for photothermal therapy, CCRF-CEM and Ramos cells incubated with nanorose-sgc8 were exposed to 810 nm laser illumination at 1.3 W cm −2 for 10 min. Irradiation of CCRF-CEM cells with nanorose-sgc8 increased the temperature to 51.3 °C, while Ramos cells incubated with nanorose-sgc8 only reached 35.7 °C ( Figure S9 , Supporting Information). Cell death after treatment with nanorose-sgc8-only, Dox-only, and nanorose-sgc8-Dox, with or without laser irradiation, was determined by using propidium iodide (PI) dye to stain the dead cells, followed by fl ow cytometry monitoring (Figure 5 c,d) . A control experiment by directly illuminating CCRF-CEM cells alone without Dox or nanorose-sgc8 treatment for different irradiation time was conducted, and negligible toxicity was observed, demonstrating the laser biocompatibility ( Figure 5 c,d , Figure S9 , Supporting Information). After Dox treatment, CCRF-CEM cell viability decreased to 59 ± 5.4%, while laser irradiation did not affect the viability signifi cantly (52 ± 0.9%). Without irradiation, the nanorose-sgc8 hybrid showed excellent biocompatibility and was not toxic to either CCRF-CEM or Ramos cells ( Figure S8 , Supporting Information). However, almost half of the CCRF-CEM cells were killed by nanorose-sgc8 after laser illumination by the specifi c binding of nanorose-sgc8 to target cells, coupled with photothermal effect. In addition, exposure to NIR irradiation increased the rate of Dox release from the nanorose-sgc8-Dox complex based on the higher temperature. As shown in Figure 5 c, when combined with photothermal therapy, 0.8 μ M of Dox released from nanorose-sgc8-Dox was suffi cient to kill about 71 ± 0.7% of the CCRF-CEM cells, while 2.0 μ M of free Dox was needed to reach the same killing effi ciency (Figure 5 a) . The synergistic effect between Dox and NIR irradiation has been well demonstrated through the addition of NIR photothermal agents to cells subjected to Dox treatment, showing enhanced Dox toxicity via NIR irradiation. [ 5a , 25 ] Therefore, smaller drug doses are suffi cient to achieve the desired therapeutic outcome under hyperthermic conditions, so that nonspecifi c toxicity and side effects can be minimized.
The specifi city of the treatment was investigated by incubating control cells (Ramos cells) with free Dox, nanorose-sgc8 and nanorose-sgc8-Dox under the same conditions as those for CCRF-CEM cells (Figure 5 d) . Cell viability of Ramos cells was higher than 85 ± 4%, even with laser irradiation, after nanorose-sgc8-Dox treatment. These results demonstrate that nanorose-sgc8-Dox shows minimal toxicity to control cells based on the specifi city of sgc8 aptamer. Taken together, the data indicate that treatment of CCRF-CEM cells with nanorose-sgc8-Dox followed by NIR laser irradiation has signifi cantly greater cytotoxic effect, compared to the treatment with nanorose-sgc8-only (photothermal therapy) or Dox-only (chemotherapy). This enhanced antitumor effect with nanorose-sgc8-Dox plus laser irradiation can be attributed to both the cytotoxic effect of Dox released from nanorose-sgc8-Dox and the photothermal effect generated by the nanoroses under NIR laser exposure. . The fi rst channel with green fl uorescence is from LysoSensor; the second channel with red fl uorescence is from Dox; the third channel is the transmission image, and the fourth channel is the overlay image of fl uorescence and transmission. Scale bars = 10 μ m. Cells were incubated at 37 °C for 2 h, followed by washing twice with washing buffer. CCRF-CEM or Ramos cells: 1 × 10 6 cells mL −1 . Nanorose-sgc8-Dox: 1.0 n M . solution (10 mL) containing FeCl 3 ·6H 2 O (1.5 g) and FeCl 2 ·4H 2 O (0.64 g) was gradually injected into the dextran solution with magnetic stirring after passing through a hydrophilic 0.22 um fi lter. After stirring for 0.5 h at room temperature, the black suspension was centrifuged at 10,000 rpm for 20 min to remove the large aggregates. Fe 3 O 4 nanoparticles in the supernatant solution were collected using an external magnetic fi eld. The concentration of Fe 3 O 4 , as determined from ICP-AES, was 240 μ g mL −1 . Nanoroses were formed by the reduction of HAuCl 4 onto the Fe 3 O 4 nanoparticles with hydroxylamine as a seeding agent. In brief, the as-prepared dextran-coated Fe 3 O 4 solution (0.5 mL) was mixed with DI water (3.5 mL). A hydroxylamine seeding agent (100 μ L, 1%, w/w) and dextrose (0.5 g) as a mild reducing agent were added, and stirring was continued for 15 min at room temperature. Then NH 4 OH solution (50 μ L, 7%, w/w) was added to the Fe 3 O 4 dispersion to tune the pH to 9.0. Every 10 min, an aliquot of HAuCl 4 aqueous solution (100 μ L, 6.348 m M ) was added to the stirred dispersion, until a total of 300 μ L of HAuCl 4 had been added. The color gradually changed from brown to dark brown during the three aliquot additions. Subsequently, the dense Fe 3 O 4 @Au particles were separated from the less dense uncoated particles by centrifugation at 8000 rpm for 6 min. The supernatant was decanted, and the nanoroses were redispersed in aqueous dextran solution (5%, w/w) by sonication for 10 min. The centrifugation and redispersion steps were repeated fi ve times to remove the uncoated Fe 3 O 4 nanoparticles, then two more times with DI water as dispersant to remove excess dextran molecules. The purifi ed particles were redispersed in Tris-HCl solution (2 mL, 10 m M , pH 7.4). The hydrodynamic diameters of nanoroses were determined by dynamic light scattering (DLS) (Microtrac Nanotrac Ultra). Zeta potential (Zetaplus, Zeta Potential Analyser, Brookhaven Instruments Co.) was used to characterize the surface charge of the nanoroses. Energy-dispersive spectroscopy (EDS) line scan coupled with scanning transmission electron microscopy (STEM) from one nanorose identifi ed the presence of Au and Fe. STEM and EDS were performed on a fi eld emission JEOL JEM-2010F transmission electron microscope equipped with an Oxford INCA EDS system. EDS line scan was taken with the microscope in STEM mode at 200 kV accelerating voltage.
DNA Synthesis : All DNA sequences (see Table S1 , Supporting Information) were synthesized on an ABI 3400 DNA/RNA synthesizer (Applied Biosystems, Foster City, CA, USA). The aptamer with fl uorescein isothiocyanate (FITC) labeling was used for fl ow cytometry, while the aptamer with tetramethylrhodamine (TAMRA) labeling was used for the study of binding and internalization of nanorose-sgc8 using confocal fl uorescence microscopy. Other experiments were carried out using the aptamer without dye labeling. The aptamers with and without FITC labeling were deprotected in AMA solution (ammonium hydroxide : 40% aqueous methylamine = 1:1) (2.5 mL) at 65 °C for 30 min. The TAMRA-labeled aptamer was deprotected in TAMRA deprotection solution (methanol : tert -butylamine : water = 1 : 1 : 2) (3 mL) at 65 °C for 4 h. Then the solution was transferred to 15 mL centrifuge tubes and mixed with NaCl (250 μ L, 3.0 M ) and cold ethanol (6.0 mL), followed by a 30 min precipitation in a −20°C freezer. The precipitated DNA oligomers were collected by centrifugation and dissolved in triethylammonium acetate (TEAA) (400 μ L, 0.1 M ). They were further purifi ed using a reversed-phase high-pressure liquid chromatography (HPLC) (ProStar, Varian, Walnut Creek, CA, USA) with a C 18 column and acetonitrile-TEAA solvent. Finally, the concentrations of these DNA oligomers were determined by measuing their absorbance at 260 nm with a UV-1800 spectrophotometer (Shimadzu, Japan).
Conjugation of sgc8 Aptamers to Nanoroses : First, thiol-functionalized capture probe and SH-PEG-COOH (Nanocs, MW 3400) were conjugated to the nanoroses following a slightly modifi ed method in the literature. [ 27 ] Before conjugation, thiol-modifed capture probe (1.0 m M ) was activated by TCEP (1.0 m M , freshly prepared) in acetate buffer (50 m M , pH 5.2) for 1 h at room temperature. SH-PEG-COOH (100 μ L, 10 m M ) and activated thiol-functionalized capture probe (40 μ L, 1.0 m M ) were added to nanorose solution (2 mL, 49.5 n M ) with gentle shaking by hand. The mixture was magnetically stirred at room temperature for at least 16 h. Then Tris acetate (60 μ L, 500 m M , pH 8.2) buffer was added dropwise to Consistent with the relaxation data, Figure 7 b shows that much darker images were observed for the left column (CCRF-CEM cells) for all three concentrations of nanorose-sgc8. These results indicate that nanorose-sgc8 has the potential to be used as a selective and effective image contrast agent for MRI application.
. Conclusions
In summary, we have developed a fi ve-function sgc8 aptamerconjugated nanorose to serve not only as an anticancer drug carrier, but also as an effi cient photothermal therapy agent to kill target cancer cells by direct heat, thereby also facilitating rapid drug release. Thus, the killing effi ciency can be improved with reduced drug doses. Our design offers several attractive features: 1) fi ve different functions synergistically integrated into a single platform by a nanorose about 70 nm in diameter; 2) enhanced specifi c binding and improved cellular uptake by multivalent effect; 3) minimum nonspecifi c toxicity and side effects based on a lower dosage of chemotherapy drugs when combined with photothermal therapy. The combination of dualmodality MRI and optical imaging has the potential to improve the specifi city of cancer cell diagnosis and facilitate therapeutic drug monitoring. The amounts of imaging agent, photothermal agent or drug loaded into the system can be adjusted to perform each function synergistically and effectively. It is expected that this versatile theranostic system will have wide biomedical applications and may be particularly useful for cancer therapy.
. Experimental Section
Materials : Iron (II) chloride tetrahydrate, Iron (III) chloride hexahydrate, Gold (III) chloride trihydrate, Doxorubicin hydrochloride, and Dextran (Mr ≈40 000) were all purchased from Sigma-Aldrich. Hydroxylamine Hydrochloride was ordered from Fisher Scientifi c.
Nanorose Synthesis : The nanoroses were prepared using methods described previously with slight modifi cations. [ 14, 18 ] First, 3-5 nm Fe 3 O 4 nanoparticles were synthesized by the co-precipitation method. An aqueous dextran solution (15 mL, 15%, w/w) was titrated with NH 4 OH solution (8mL, >25%, w/w) to pH 11.7. Then a freshly prepared aqueous PA, USA), with a 60× oil-dispersion objective. A 488 nm argon laser was used as the excitation source for FITC dye, and a 543 nm argon laser was used for the excitation of TAMRA dye or Dox. For the specifi c binding test, the treatment steps for cell incubation were the same as those described for the fl ow cytometry analysis. For the colocalization study of internalization or Dox release toward different cell lines, free sgc8, nanorose-sgc8, or nanorose-sgc8-Dox was incubated with CCRF-CEM or Ramos cells (1 × 10 6 cells mL −1 ) in binding buffer (200 μ L) at 37 °C for 2 h with a 5% CO 2 atmosphere. Five μ M LysoSensor was added for specifi c staining of the lysosomes of cancer cells during the last 0.5 h of the 2 h incubation. The cells were then washed twice with washing buffer, resuspended in binding buffer (200 μ L), and subjected to confocal fl uorescence microscopy.
Cytotoxicity Assay : The cytotoxicity of free Dox, nanorose-sgc8 and nanorose-sgc8-Dox to CCRF-CEM and Ramos cells before and after laser irradiation was evaluted using a FACScan cytometer. CCRF-CEM or Ramos cells (1 × 10 6 cells mL −1 ) were fi rst incubated with various concentrations of Dox-only, nanorose-sgc8-only or nanorose-sgc8-Dox in binding buffer (200 μ L) at 37 °C for 2 h with a 5% CO 2 atmosphere, then washed twice with washing buffer. Cells were then exposed to 810 nm laser illumination for 10 min and returned to the incubator for another 48 h. Then cells were stained with propidium iodide (PI; Invitrogen, Carlsbad, CA, USA) at room temperature for 15 min to test cell viability. Dead cells, which can accumulate the dye and show red fl uorescence, were determined by fl ow cytometric analysis. The cell viability was determined by comparing cells treated with Dox, nanorose-sgc8 and nanorose-sgc8-Dox with the corresponding untreated controls.
Photothermal Therapy : The nanoroses absorb in the NIR at 805 nm, which is close to the laser wavelength at 810 nm. Temperature curves were recorded in real time with a COHERENT Quarto-FAP system, while cells were illuminated with an 810 nm continuous wave laser at 1.3 W cm −2 for 10 min.
Relaxation Time Measurement and Magnetic Resonance Imaging : The spin-spin relaxation times ( T 2 ) were measured at 1.4 T by a standard CarrPurcell-Meiboom-Gill Sequence on a benchtop Mninispec mq60 TD-NMR contrast agent analyzer (Minispec, Bruker, Germany) operating at 37 °C. Nanoroses-only and nanorose-sgc8 with CCRF-CEM or Ramos cells (1 × 10 6 cells mL −1 ) were incubated on ice for 30 min in binding buffer (250 μ L). Then all samples were transferred to NMR sample tubes and subjected to T 2 relaxation measurements, without any further washing steps. T 2 -weighted MRI images were acquired on a 4.7 T/200 MHz MRI spectrometer (Bruker Optics, Billerica, MA), following the same treatment steps as performed for the T 2 relaxation measurements.
Supporting Information
Supporting Information is available form the Wiley Online Library or from the author. It includes the nanorose characterization, Dox loading and release, binding and internalization of nanorose-sgc8 to CCRF-CEM and Ramos cells using a confocal fl uorescence microscope, cytotoxicity of nanorose-sgc8 to CCRF-CEM and Ramos cells. the solution with gentle hand shaking, followed by dropwise addtion of NaCl (600 μ L, 1.0 M ). The solution was sonicated for 15 s and then stored at room temperature for 24 h. The free capture probe and SH-PEG-COOH were removed by centrifugation at 14 000 rpm for 5 min, and the nanoroses were redispersed in 2 mL Tris-Mg buffer (10 m M Tris-HCl, pH 7.4, containing 100 m M NaCl, 10 m M KCl, and 10 m M MgCl 2 ). The resulting nanoroses were then hybridized with extended sgc8 aptamer (40 μ L, 1.0 m M ) by initally heating the solution to 90 °C for 5 min, followed by incubating at room temperature for 1 h. Unreacted sgc8 was removed by centrifugation at 14 000 rpm for 5 min, and nanorose-sgc8 hybrids were redispersed in Tris-HCl buffer (2 mL, pH 7.4) .
Dox Loading of Nanorose-sgc8 : The maximum achievable loading of Dox onto nanorose and nanorose-sgc8 (both modifed with SH-PEG-COOH) was determined by measuring the unloaded Dox fl uorescence in the supernatant. Serial concentrations of nanorose and nanorose-sgc8 (0, 0.16, 0.4, 1.6, 4.0 n M ) were added to a fi xed concentration of Dox (5.5 μ M ) with PBS buffer pH 7.4 and incubated at room temperature for 10 min with gentle shaking. The unloaded Dox was removed by centrifugation at 10,000 rpm for 3 min. The concentration of unloaded Dox in the supernatant was calculated from the emission intensity of Dox at 590 nm with excitation at 480 nm, using a Fluorolog-3 spectrofl uorometer (Jobin Yvon Horiba).
Dox Release Kinetics : The release of Dox from the nanorose-sgc8-Dox complex was conducted by incubating nanorose-sgc8-Dox in PBS buffers with different pH values (pH = 5.0, 7.4) at different temperatures ( T = 25 °C, 37 °C, 65 °C). At the indicated times, the particles were collected by centrifugation, and the supernatant was removed for fl uorescence analysis and replaced with fresh buffer. The amount of Dox released was accumulated by determining the fl uorescence emission of the supernatant at 590 nm at selected time intervals.
Cell Culture : CCRF-CEM (CCL-119 T-cell, human acute lymphoblastic leukemia) and Ramos (CRL-1596, B-cell line, human Burkitt's lymphoma) were cultured in RPMI 1640 medium (American Type Culture Collection) with 10% heat inactivated fetal bovine serum (FBS, Invitrogen, Carlsbad, USA) and penicillin-streptomycin (100 IU/mL, GIBCO) at 37 °C under a 5% CO 2 atmosphere. The cell density was determined using a hemocytometer (Hausser Scientifi c) and a microscope (Olympus).
Flow Cytometry Analysis : Flow cytometry analysis was performed on a FACScan cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA) to demonstrate the specifi c targeting of nanorose-sgc8 to CCRF-CEM cells. The binding affi nities of free sgc8 and nanorose-sgc8 functionalized with FITC dye were determined by incubating CCRF-CEM or Ramos cells (1 × 10 6 cells mL A green laser at 488 nm was used as the excitation source, and the FITC-labeled random ssDNA library was used as a negative control. To study the internalization of free sgc8 and nanorose-sgc8, CCRF-CEM or Ramos cells (1 × 10 6 cells mL −1 ) were fi rst incubated with various concentrations of sgc8 and nanorose-sgc8 in binding buffer (200 μ L) at 37 °C for 2 h with a 5% CO 2 atmosphere, then washed with washing buffer twice. Then cells were incubated with trypsin (500 μ L, 0.05%)/ EDTA (0.53 m M ) in Hank's Balanced Salt Solution (HBSS) at 37 °C for 10 min. After incubation, FBS (50 μ L) was added to quench the function of trypsin, and the cells were washed with washing buffer once again and suspended in binding buffer (200 μ L) for fl ow cytometric analysis.
Confocal Imaging : To investigate the specifi c binding and internalization of free sgc8 and nanorose-sgc8 toward different cell lines by confocal imaging, the aptamers were labeled with TAMRA dye. However, for the colocalization study of Dox release, aptamers without dye labeling were used. All cellular fl uorescence images were collected on an Olympus FV 500-IX81 confocal microscope (Olympus, Center Valley,
